When ischemic stroke patients do not receive intravelous alteplase to help dissolve clots, their odds of survival are significantly reduced, according to a study published in the American Journal of ...

Patients 80 years of age or older who received intravenous tissue plasminogen activator (IV tPA) for acute ischemic stroke had double the mortality rate compared with those who were untreated, a study ...

Outcomes after stroke thrombectomy were not better with tissue plasminogen activator (tPA) withheld, according to the MR CLEAN-NO IV trial. Of more than 500 acute stroke patients with large vessel ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Among patients with acute ischemic stroke ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window DALLAS -- Dual ...

Among patients presenting directly to a thrombectomy-equipped center with a large-vessel ischemic stroke, going directly to the endovascular suite and forgoing initial IV thrombolytic therapy provides ...

Patients with acute stroke benefit from thrombolysis with IV tissue plasminogen activator (tPA). In the last decade, a number of endovascular techniques have increasingly been used to open blood ...

Ischemic stroke patients who do not receive intravelous (IV) alteplase, a clot-dissolving medication, are significantly less likely to survive, according to researchers. Ischemic stroke patients who ...

For patients who present to a thrombectomy-capable center, a direct trip to endovascular therapy does not improve functional outcomes compared with the guideline-recommended approach of giving IV ...

Please provide your email address to receive an email when new articles are posted on . Among patients with major acute ischemic stroke who underwent endovascular therapy, those assigned IV nerinetide ...

Honolulu, Hawaii — A new trial shows outcomes with endovascular revascularization are not superior to those achieved with intravenous (IV) thrombolysis in the treatment of acute ischemic stroke. The ...

A major international analysis of 2,313 patients, median age 71, found that giving an IV clot-busting drug before mechanical clot removal modestly increases brain-bleeding risk compared with ...